SBI-101
Sponsors
Sentien Biotechnologies, Inc.
Conditions
Acute Kidney InjuryCOVID-19Sepsis
Phase 1
A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy
NCT03015623
Start: 2017-06-20End: 2021-12-31Target: 24Updated: 2021-03-16
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
NCT04445220
Start: 2020-11-19End: 2022-09-30Target: 22Updated: 2022-01-14